RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat HER2+ cancers
Disease control Recruiting nowThis study compares two drugs, neratinib and palbociclib, used together versus neratinib alone for people with HER2-positive gynecologic and other solid tumors (excluding breast cancer). The goal is to see if the combination can shrink or slow cancer growth. About 70 adults with …
Matched conditions: RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Gene-Guided cancer therapy: a new hope for advanced tumors?
Knowledge-focused Recruiting nowThis study screens patients with advanced solid tumors to find genetic changes in their cancer cells. Based on those results, patients may be matched to a treatment trial that targets their specific tumor mutations. The goal is to improve how doctors choose combination therapies …
Matched conditions: RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC